Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.
Among the hallmark phenotypes reported in individuals with fragile X syndrome (FXS) are deficits in attentional function, inhibitory control, and cognitive flexibility, a set of cognitive skills thought to be associated with the prefrontal cortex (PFC). However, despite substantial clinical research into these core deficits, the PFC has received surprisingly little attention in preclinical research, particularly in animal models of FXS. In this study, we sought to investigate the molecular, cellular, and behavioral consequences of the loss of the fragile X mental retardation protein in the PFC of Fmr1 KO mice, a mouse model of FXS. We identify a robust cognitive impairment in these mice that may be related to the deficits in cognitive flexibility observed in individuals with FXS. In addition, we report that levels of proteins involved in synaptic function, including the NMDA receptor subunits NR1, NR2A, and NR2B; the scaffolding proteins PSD-95 and SAPAP3; and the plasticity-related gene Arc, are decreased in the prefrontal cortex of Fmr1 KO mice and are partly correlated with behavioral performance. Finally, we report that expression of c-Fos, a marker of neuronal activity, is decreased in the PFC of Fmr1 KO mice. Together, these data suggest that Fmr1 KO mice may represent a valuable animal model for the PFC-associated molecular, cellular, and behavioral abnormalities in FXS and that this model may be useful for testing the efficacy of therapeutic strategies aimed at treating the cognitive impairments in FXS.
Howard Hughes Medical Institute, Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Dilja D
DD
Krueger
Emily K
EK
Osterweil
Stephanie P
SP
Chen
Lynne D
LD
Tye
Mark F
MF
Bear
D000818:Animals; D000943:Antigens, Differentiation / Q000235:genetics / Q000378:metabolism; D001522:Behavior, Animal; D003072:Cognition Disorders / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D005600:Fragile X Syndrome / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D013569:Synapses / Q000378:metabolism* / Q000473:pathology
D000943:Antigens, Differentiation; D009419:Nerve Tissue Proteins
Nature. 2007 Aug 23;448(7156):894-900
17713528
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50
12032354
Nat Rev Neurosci. 2009 Dec;10(12):885-92
19904278
Mol Cell Neurosci. 2002 Feb;19(2):138-51
11860268
Mol Psychiatry. 2004 Apr;9(4):417-25
14981523
J Biol Chem. 2010 Jul 9;285(28):21888-901
20457613
Neuron. 2008 Aug 28;59(4):634-47
18760699
Pharmacol Ther. 2010 Dec;128(3):419-32
20705091
J Med Genet. 2009 Feb;46(2):94-102
18835858
Trends Neurosci. 2004 Jul;27(7):370-7
15219735
Neuron. 2010 Feb 11;65(3):373-84
20159450
J Neuropsychiatry Clin Neurosci. 2002 Fall;14(4):377-405
12426407
Biol Psychol. 2006 Jul;73(1):19-38
16546312
Cell. 2008 Oct 31;135(3):401-6
18984149
J Neurosci. 1985 Aug;5(8):2240-53
2991484
Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
12373437
Neuropsychologia. 2002;40(8):1343-9
11931937
J Neurosci. 2005 Sep 28;25(39):8908-16
16192381
Nat Rev Neurosci. 2010 Jul;11(7):490-502
20559336
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5401-4
9144249
Int J Neuropsychopharmacol. 2011 Jun;14(5):618-30
20497624
J Biol Chem. 2009 Sep 18;284(38):25479-87
19640847
Behav Neurosci. 2006 Dec;120(6):1367-79
17201482
Nat Neurosci. 2007 May;10(5):578-87
17417632
Neuron. 2007 Dec 20;56(6):955-62
18093519
Neuron. 2008 Oct 23;60(2):201-14
18957214
Neurosci Biobehav Rev. 2004 Nov;28(7):771-84
15555683
Neuron. 1990 Apr;4(4):477-85
1969743
Neuroscience. 1997 Jan;76(2):367-76
9015322
Eur J Neurosci. 2010 Nov;32(10):1726-34
21044173
J Neurosci. 2005 May 18;25(20):5087-95
15901791
Child Adolesc Psychiatr Clin N Am. 2007 Jul;16(3):663-75
17562585
Neuron. 2008 Jul 10;59(1):70-83
18614030
Cell. 1994 Jul 15;78(1):23-33
8033209
Neuropharmacology. 2005 Dec;49(7):1053-66
16054174
Biol Psychiatry. 2010 Jul 1;68(1):5-16
20488434
Dev Sci. 2004 Feb;7(1):116-30
15323123
Dev Disabil Res Rev. 2009;15(4):343-52
20014368
Annu Rev Genomics Hum Genet. 2007;8:109-29
17477822
Behav Pharmacol. 2004 Sep;15(5-6):433-42
15343070
Neuron. 2007 May 24;54(4):627-38
17521574